Varying Presentations in Patients With Symptomatic Type IV Vascular Ehlers-Danlos Syndrome

Abstract

Ehlers-Danlos syndrome (EDS) represents a group of inheritable connective tissue disorders. Patients with type IV or vascular EDS, autosomal dominant pattern of inheritance, may present with aneurysm formation or arterial dissection. Due to vessel fragility, operative therapy for such disorders has been reserved for compelling indications in which benefit clearly warrants risk, yet assessment of risk is largely clinical with operative decisions guided by factors such as response to previous operations and age at onset of index vascular complications. We present 2 patients with differences in their clinical presentations and outcomes and review the literature with emphasis on operative decision making.

Keywords

connective tissue vascular Ehlers-Danlos syndrome

Get full access to this article

View all access options for this article.

References

Beighton

De Paepe

Steinmann

Tsipouras

Wenstrup

RJ.

Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet. 1998;77(1):31–37.

Pope

Nicholls

Jones

Wells

Lawrence

EDS IV (acrogeria): new autosomal dominant and recessive types. J R Soc Med. 1980;73(3):180–186.

Ehlers

Cutis laxa, neigung zu haemorrhagien in der haut, lockerung mehrerer artikulationen. Dermatol Z. 1901;8:173–175.

Danlos

Un cas de cutis laxa avec tumeurs par contusion chronique des coudes et des genoux. Bull Soc Derm Syph. 1908;19:70–72.

Kitsiou-Tzeli

Leze

Salavoura

. Long term follow up of a woman with classic form of Ehlers-Danlos syndrome associated with rare manifestations and review of the literature. Genet Couns. 2010;21(1):75–83.

Brooke

Arnaoutakis

McDonnell

Black JH

3rd.

Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010;51(1):131–138.

Parapia

Jackson

Ehlers-Danlos syndrome—a historical review. Br J Haematol. 2008;141:32–35.

Barabas

AP.

Heterogeneity of the Ehlers-Danlos syndrome: description of three clinical types and a hypothesis to explain the basic defect. BMJ. 1967;2(5552):612–613.

Barabas

AP.

Vascular complications in the Ehlers-Danlos syndrome, with especial reference to the “arterial type” or Sack’s syndrome. J Cardiovasc Surg. 1972;13(2):160–167.

10.

Pepin

Schwarze

Superti-Furga

Byers

PH.

Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342(10):673–680.

11.

Oderich

Panneton

Bower

. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. Vasc Surg. 2005;42(1):98–106.

12.

Germain

DP.

Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002;16(3):391–397.

13.

Byers

PH.

Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. J Invest Dermatol. 1994;103(5 suppl):47S–52S.

14.

Pyeritz

RE.

Ehlers-Danlos syndrome (editorial). N Eng J Med. 2000;342(10):730–732.

15.

Mitchell

Schwarze

Jennings

Byers

PH.

Molecular mechanisms of classical Ehlers-Danlos syndrome (EDS). Hum Mutat. 2009;30(6):995–1002.

16.

Bergqvist

Ehlers-Danlos type IV syndrome: a review from a vascular surgical point of view. Eur J Surg. 1996;162(3):163–170.

17.

Ong

Perdu

De Backer

. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376(9751):1476–1484.